Scinai Immunotherapeutics Filing Covers 7.6 Million ADS Offered by Selling Shareholders
An SEC filing says the offering relates to 7.6 million ADS representing 303.50 billion ordinary shares, by selling shareholders.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Scinai Immunotherapeutics SEC Filing Relates to 7.6 Million ADS Offering
A SEC filing relates to an offering of 7.6 million ADSs representing 303.50 billion ordinary shares by selling shareholders.
Scinai Immunotherapeutics Filing Relates to Offering of 7.6 Million ADSs
A SEC filing says the offering relates to 7.6 million ADSs representing 303.50 billion ordinary shares, sold by shareholders.